Back to Results
First PageMeta Content
Benzofurans / Dronedarone / Sulfonamides / Amiodarone / Atrial fibrillation / Sanofi / Chemistry / Organic chemistry / Antiarrhythmic agents


DIONYSOS Study Results Showed the Respective Profiles of Dronedarone and Amiodarone Paris, France – December 23, 2008 – Sanofi-aventis (Paris Bourse: EURONEXT: SAN; and New
Add to Reading List

Document Date: 2009-06-24 11:29:31

Open Document

File Size: 89,02 KB

Share Result on Facebook

City

New York / Paris / /

Company

Sanofi / sanofi-aventis / /

Country

France / /

/

Event

FDA Phase / Company Listing Change / /

Facility

St George’s University of London / /

IndustryTerm

therapeutic solutions / pharmaceutical / /

MedicalCondition

persistent Atrial Fibrillation / /

MedicalTreatment

cardioversion / investigational treatment / /

Organization

U.S. Food and Drug Administration / University of London / /

Person

Pr John Camm / /

Position

investigator / Major / /

Product

Multaq® / /

Technology

SAN / therapeutic solutions / /

URL

www.sanofi-aventis.com / /

SocialTag